OOIR: Observatory of International Research

Papers

(The H4-Index of Pharmacotherapy is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Update and narrative review of avian influenza (H5N1) infection in adult patients	98
Characterization of lamotrigine disposition changes during and after pregnancy in women with epilepsy	94
	67
Changes in serum potassium in people with type 2 diabetes taking sodium‐glucose co‐transporter‐2 inhibitors	54
Warfarin dosage in a postpartum woman while breastfeeding: A case report	52
Association of bleeding with serotonergic antidepressants in patients receiving left ventricular assist device support	42
Acid‐suppressive drugs: A systematic review and network meta‐analysis of their nocturnal acid‐inhibitory effect	39
Hydroxyurea treatment for sickle cell anemia during pregnancy and lactation: Current evidence and knowledge gaps	39
Comparison of risk‐scoring systems for heparin‐induced thrombocytopenia in cardiac surgery patients	38
Empiric dosing strategies to predict lamotrigine concentrations during pregnancy	35
Safety and efficacy of cefiderocol for off‐label treatment indications: A systematic review	35
Assessment and management of iatrogenic withdrawal syndrome and delirium in pediatric intensive care units across Europe: An ESPNIC survey	35
Comparative safety and efficacy of bisphosphonates, denosumab, and parathyroid hormone analogs for osteoporosis following lung transplantation	30
Reduced risk of NSAID‐Induced adverse events with concomitant use of misoprostol (MICRO study)	29
Impact of concurrent gabapentin or pregabalin with high‐dose melphalan in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant	29
	29
Statin‐associated muscle symptoms—A review: Individualizing the approach to optimize care	29
Optimal starting dosing regimen of intravenous oxytocin for labor induction based on the population kinetic‐pharmacodynamic model of uterine contraction frequency	28
Patient safety outcomes for continuous infusion vancomycin as outpatient parenteral antimicrobial therapy	27
Determination of vancomycin exposure target and individualized dosing recommendations for critically ill patients undergoing continuous renal replacement therapy	27
Biomarkers in the intensive care setting: A focus on using procalcitonin and C‐reactive protein to optimize antimicrobial duration of therapy	27
Response to comment on “Dosing implications for liposomal amphotericin B in pregnancy”	26
Comment on “Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution”	25
Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment‐experienced and/or have multidrug‐resistant HIV‐1: Endorse	24